Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEGeneral Updates▲ PositiveResults29 Oct 2026

CARE Ratings Limited

General Updates

CARE Ratings Limited has informed the Exchange about Investor Presentation and declared its unaudited financial results for the quarter and half year ended September 30, 2026. The results show a 17% and 20% increase in operating income and EBITDA margin respectively. The company has also reported a 21% and 26% increase in PAT and PAT margin respectively. The Board of Directors have expressed confidence in the Indian economy's resilience amidst global headwinds, and the company's performance is expected to remain healthy in FY27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Oct 2026

CARE Ratings Ltd

Investor Presentation

CARE Ratings Ltd has announced its unaudited financial results for Q2 and H1 FY27, showing a 17% and 20% YoY growth in operating income, respectively. The company has reported a PAT of Rs. 22.98 Cr and Rs. 34.25 Cr for Q2 and H1 FY27, respectively. The Indian economy has shown resilience amidst global headwinds, with a GDP growth of 7.8% in Q1 FY27 and a projected full-year GDP growth of 7.3%. The company has also highlighted the improvement in fund-raising activity in the economy, with commercial paper issuances increasing by 24.1% YoY in H1 FY27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Oct 2026

CARE Ratings Ltd

Press Release

CARE Ratings Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 17% and 20% YoY increase in operating income, respectively. The company reported a 24% and 26% YoY increase in EBITDA and EBITDA margin, respectively. The PAT and PAT margin also increased by 21% and 34%, respectively. The company's EPS was Rs. 22.98 and Rs. 34.25 for the quarter and half year, respectively. The company's revenue segmental contribution showed a 21% and 20% YoY increase in ratings business and non-ratings business, respectively.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Oct 2026

Mehta Securities Ltd

Mehta Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Board meeting for consideration and approval of unaudited financial results of the Company for the quarter ended on 30.09.2026 under reg, 29 of SEBI(LODR) Reg, 2015

Mehta Securities Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 06/11/2026 to consider and approve unaudited financial results for the quarter ended 30.09.2026.

Read more →📎 1 attachment
NSEInvestor PresentationResults29 Oct 2026

Seshaasai Technologies Limited

Investor Presentation

Seshaasai Technologies Limited has announced its Q2FY27 earnings, with revenue from operations at ₹4,053.1 Mn, EBITDA at ₹1,065.6 Mn, and PAT at ₹697.3 Mn, showing a YoY growth of 15.0% in revenue, 12.0% in EBITDA, and 21.0% in PAT.

Read more →📎 1 attachment
BSECompany UpdateResults29 Oct 2026

Ind-Swift Laboratories Ltd

Please refer attached pdf

Ind-Swift Laboratories Ltd has issued a nil statement on deviation or variation of funds raised through a preferential issue of 70,00,000 fully convertible warrants, confirming that there has been no deviation or variation in the utilization of funds raised.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Oct 2026

CARE Ratings Limited

Press Release

CARE Ratings Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 17% and 20% YoY increase in operating income and a 24% and 26% YoY increase in EBITDA margin.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Oct 2026

EPACK Durable Limited

Press Release

EPACK Durable Limited has announced its Q2 FY27 financial results, with revenue rising 106.0% YoY to INR 4,393 Mn, and EBITDA improving by INR 146 Mn YoY to a profit of INR 71 Mn. The company has also announced the transfer of its 50% stake in the EPAVO Electricals joint venture to its partner, the Ram Ratna Group, and the winding up of two subsidiaries.

Read more →📎 1 attachment
NSEStatement of deviation(s) or variation(s) under Reg. 32Results29 Oct 2026

Ind-Swift Laboratories Limited

Statement of deviation(s) or variation(s) under Reg. 32

Ind-Swift Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the utilization of funds raised through the preferential issue of 70,00,000 Fully Convertible Warrants. The company confirms that there has been no deviation or variation in the utilization of funds.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Oct 2026

Mehta Integrated Finance Ltd

Mehta Integrated Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Intimation for board meeting for consideration and approval of unaudited financial results for the quarter and half year ended on 30.09.2026 under reg, 29 if SEBI(LODR) Reg, 2025

Mehta Integrated Finance Ltd has scheduled a board meeting on 06/11/2026 to consider and approve unaudited financial results for the quarter and half year ended 30.09.2026.

Read more →📎 1 attachment
← PreviousPage 1204 of 4523Next →